13 Recruiting Endometrial Neoplasms Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Endometrial Neoplasms Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
📍 Research Site — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
📍 UAMS — Little Rock, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
📍 HonorHealth-USOR HonorHealth ( Site 8000) — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
📍 University of Alabama - Birmingham ( Site 3061) — Birmingham, Alabama
View Study & Checklist ➔ NOT_YET_RECRUITING phase3 Protocol
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
📍 Jupiter Medical Center/ Anderson Family Cancer Institute — Jupiter, Florida
View Study & Checklist ➔